Dimethylargininase, a nitric oxide regulatory protein, in Alzheimer disease

Mark A. Smith*, Milan Vašák, Markus Knipp, Rudy J. Castellani, George Perry

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

56 Scopus citations

Abstract

In this study, we show that dimethylargininase, a zinc protein involved in the regulation of nitric oxide synthase, is specifically elevated in neurons displaying cytoskeletal abnormalities and oxidative stress in Alzheimer disease (AD) while none of this enzyme was found in neurons in age- matched control cases. Seen in the context of earlier studies showing widespread nitric oxide related damage in AD and the role of dimethylargininase to activate nitric oxide synthetase, through catalytic removal of its endogenous inhibitors, these findings indicate major alterations in nitric oxide regulation in AD. Further, that low levels of zinc specifically inhibit dimethylargininase may provide a link between the numerous studies showing specific abnormalities in zinc and oxidative stress. Finally, our results provide additional evidence that oxidative stress- and nitric oxide-mediated events play important roles in the pathogenesis of AD.

Original languageEnglish (US)
Pages (from-to)898-902
Number of pages5
JournalFree Radical Biology and Medicine
Volume25
Issue number8
DOIs
StatePublished - Nov 15 1998

Funding

This work was supported through grants from the National Institutes of Health (MAS, GP), the American Health Assistance Foundation (MAS, GP) and by financial support from the Swiss National Science Foundation Grant 31-49460.096 (MV).

Keywords

  • Alzheimer disease
  • Nitric oxide
  • Oxidative stress
  • Transition metals
  • Zinc

ASJC Scopus subject areas

  • Biochemistry
  • Physiology (medical)

Fingerprint

Dive into the research topics of 'Dimethylargininase, a nitric oxide regulatory protein, in Alzheimer disease'. Together they form a unique fingerprint.

Cite this